Cadrenal Therapeutics, Inc. (CVKD) Form 8-K — Jul 10, 2026
James J. Ferguson III has resigned from his position as Chief Medical Officer of Cadrenal Therapeutics, Inc., effective July 31, 2026. The Board of Directors was advised of his decision on July 7, 2026. Cadrenal Therapeutics is currently conducting a search for Dr.
Price after filing
1 day: 0.0%7 days: -25.3%30 days: -32.5%
Close on the filing date to close N calendar days later (from $2.89). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.